✦ LIBER ✦

Does combination of lipid formulation of amphotericin B and echinocandins improve outcome of invasive aspergillosis in hematological malignancy patients?

✍ Scribed by Coralia N. Mihu; Christelle Kassis; Elizabeth R. Ramos; Ying Jiang; Ray Y. Hachem; Issam I. Raad

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 158 KB
Volume: 116
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.25312

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Itraconazole added to a lipid formulatio

Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosis

✍ Dimitrios P. Kontoyiannis; Maha Boktour; Hend Hanna; Harrys A. Torres; Ray Hache 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

## Abstract ## BACKGROUND Invasive aspergillosis (IA) is associated with poor outcome in patients with hematologic malignancy treated with amphotericin B (AMB)‐based therapy. Itraconazole (ITC), a triazole with activity against __Aspergillus__, has been used in combination with AMB or lipid formul

Efficacy and toxicity of caspofungin in

Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies

✍ Dimitrios P. Kontoyiannis; Ray Hachem; Russell E. Lewis; Gustavo A. Rivero; Harr 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

## Abstract ## BACKGROUND Caspofungin (CAS) as salvage therapy for refractory invasive aspergillosis (IA) had a response rate of 45% among a heterogeneous group of patients. The use of CAS with other agents is appealing given its unique mechanism of action. Therefore, the authors retrospectively e